Summary
Islet-activating protein (IAP), one of the pertussis toxins, serving [α-32P]nicotinamide adenine dinucleotide (NAD) as a substrate for ADP ribosylation, radiolabelled a specific pig epidermal membrane protein. The IAP-specific substrate was detectable by sodium dodecyl sulphate-polyacrylamide gel electrophoresis as a single band corresponding to a molecular weight of 40 kDa. The ADP ribosylation catalysed by IAP was inhibited by the addition of Mg2+ to the reaction mixture. IAP is known to work on intact cell systems resulting in the ADP ribosylation using intracellular NAD as the ADP ribose donor. Following IAP pretreatment of intact pig epidermis, the epidermal receptor adenylate cyclase responses were markedly increased; all the stimulatory receptor adenylate cyclase reponses (beta-adrenergic, prostaglandin E, adenosine and histamine responses) were significantly increased. Cholera toxin-induced cyclic AMP accumulation was also significantly increased. Forskolin-induced cyclic AMP accumulation was slightly increased after IAP pretreatment, but this was not statistically significant. The IAP-dependent ADP ribosylation of the epidermal 40 kDa membrane protein, which was prepared from the IAP pretreated epidermis, was significantly decreased. It is known that the tumour promoter, phorbol 12-myristate,13-acetate (PMA), decreases stimulatory receptor adenylate cyclase responses of the epidermis. Following the PMA pretreatment, IAP-dependent ADP ribosylation of the epidermal membrane protein was unaffected. Furthermore, following the PMA pretreatment, the IAP-induced increase in the epidermal receptor adenylate cyclase responses still remained. Our results indicate that pig epidermis contains 40 kDa membrane substrate for IAP-dependent ADP ribosylation, which has an inhibitory tonus on the epidermal adenylate cyclase until its ADP ribosylation by IAP. The results are consistent with the view that the epidermis contains an IAP-sensitive inhibitory guanine nucleotide binding protein (Gi) of the adenylate cyclase system. Although PMA decreases epidermal stimulatory receptor adenylate cyclase responses, it is unlikely that PMA reveals its effect through the modulation of Gi.
Similar content being viewed by others
References
Adachi K, Halprin KM, Takeda J, Nemoto O, Aoyagi T, Iizuka H, Yoshikawa K, Levine V (1982) Epidermal surface receptors which link pharmacological mediators to the adenylate cyclase system. Br J Dermatol 107 [Suppl]:111–118
Asano T, Katada T, Gilman AG, Ross EM (1984) Activation of the inhibitory GTP binding protein of adenylate cyclase, Gi, by beta-adrenergic receptors in reconstituted phospholipid vesicles. J Biol Chem 259:9351–9354
Bokoch GM, Katada T, Northup JK, Ui M, Gilman AG (1984) Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J Biol Chem 259:3560–3567
Fisher GJ, Baldassare JJ, Voorhees JJ (1989) GTP-dependent hydrolysis of phosphatidylinositol-4,5-bisphosphate by soluble phospholipase C from adult human epidermis. J Invest Dermatol 92:831–836
Garte SJ, Belman S (1980) Tumour promoter uncouples beta-adrenergic receptor from adenyl cyclase in mouse epidermis. Nature 284:171–173
Gilman AG (1987) G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56:615–649
Iizuka H, Kajita S, Ohkawara A (1985) Ultraviolet radiation augments epidermal beta-adrenergic adenylate cyclase response. J Invest Dermatol 84:401–403
Iizuka H, Kajita S, Mizumoto T, Kawaguchi H (1986) Glucocorticoid-induced modulation of the beta-adrenergic adenylate cyclase response of epidermis: its relation to epidermal phospholipase A2 activity. J Invest Dermatol 87:577–581
Iizuka H, Matsuo S, Tamura T, Ohkuma N (1988) Increased cholera toxin-, and forskolin-induced cyclic AMP accumulations in psoriatic involved versus uninvolved or normal human epidermis. J Invest Dermatol 91:154–157
Iizuka H, Sakai H, Tamura T (1989) Effects of the tumour promoter, phorbol 12-myristate,13-acetate, on the epidermal adenylate cyclase system: evidence for adenylate cyclase-regulation by protein kinase C. J Invest Dermatol 93:387–391
Itoh H, Toyama R, Kozawa T, Tsukamoto T, Matsuoka M, Kaziro Y (1988) Presence of three distinct molecular species of Gi protein alpha subunit. J Biol Chem 263:6656–6664
Kahn RA, Gilman AG (1984) Purification of a protein cofactor required for ADP ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J Biol Chem 259:6228–6234
Katada T, Ui M (1982) ADP-ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 257:7210–7216
Katada T, Ui M (1982) Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci USA 79:3129–3133
Katada T, Gilman AG, Watanabe Y, Bauer S, Jakobs KH (1985) Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem 151:431–437
Katada T, Oinuma M, Ui M (1986) Two guanine nucleotide binding proteins in rat brain serving as the specific substrate of islet-activating protein, pertussis toxin. J Biol Chem 261:8182–8191
Katada T, Oinuma M, Kusakabe K, Ui M (1987) A new GTP-binding protein in brain tissues serving as the specific substrate of islet-activating protein, pertussis toxin. FEBS Lett 213:353–358
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275
Murayama T, Ui M (1983) Loss of the inhibitory function of the guanine nucleotide regulatory component of adenylate cyclase due to its ADP-ribosylation by islet-activating protein, pertussis toxin, in adipocyte membranes. J Biol Chem 258:3319–3326
Neer EJ, Clapham DE (1988) Roles of G protein subunits in transmembrane signalling. Nature 333:129–134
Nukada T, Tanabe T, Takahashi H, Noda M, Haga K, Haga T, Ichiyama A, Kangawa K, Hiranaga M, Matsuo H, Numa S (1986) Primary structure of the alpha-subunit of the bovine adenylate cyclase-inhibiting G-protein deduced from the cDNA sequences. FEBS Lett 197:305–310
Schramm M, Selinger Z (1984) Message transmission: receptor-controlled adenylate cyclase system. Science 225:1350–1356
Takeda J, Adachi K, Halprin KM, Levine V, Woodyard C (1983) Adenylate cyclase activation by cholera toxin in pig epidermis: an obligatory role of the GTP-regulatory protein. J Invest Dermatol 81:131–136
Tamura M, Nogimori K, Murai S, Yajima M, Ito K, Katada T, Ui M, Ishii S (1982) Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 21:5516–5522
Tamura M, Nogimori K, Yajima M, Ase K, Ui M (1983) A role of the B oligomer moiety of islet activating protein, pertussis toxin, in development of the biological effects on intact cells. J Biol Chem 258:6756–6761
Ui M, Katada T, Nogimori K, Tamura M, Yajima M (1986) Pertussis toxin, islet-activating protein (IAP). Tanpakushitsu Kakusan Koso 31:300–323 (in Japanese)
Watanabe M, Iizuka H (1987) Adenylate cyclase-cyclic AMP system in pure epidermis isolated by use of dispase. J Dermatol (Tokyo) 14:336–342
Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Nogimori Y, Mizushima Y, Nakase Y, Ui M (1978) Islet-activating protein in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem (Tokyo) 83:295–303
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsutsui, M., Iizuka, H. Inhibitory guanine nucleotide binding protein in pig epidermis: regulation of epidermal adenylate cyclase. Arch Dermatol Res 282, 469–474 (1990). https://doi.org/10.1007/BF00402625
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00402625